SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,464 | -57.1% | 39,119 | -7.1% | 0.00% | -50.0% |
| Q2 2023 | $54,744 | -31.6% | 42,111 | +158.5% | 0.00% | -60.0% |
| Q3 2022 | $80,000 | -72.8% | 16,290 | -67.8% | 0.01% | -58.3% |
| Q1 2022 | $294,000 | +39.3% | 50,600 | +80.1% | 0.01% | +33.3% |
| Q4 2021 | $211,000 | -26.5% | 28,100 | -11.9% | 0.01% | -43.8% |
| Q3 2021 | $287,000 | -54.3% | 31,908 | -39.1% | 0.02% | -60.0% |
| Q2 2021 | $628,000 | +115.1% | 52,424 | +125.2% | 0.04% | +185.7% |
| Q1 2021 | $292,000 | -66.7% | 23,280 | -74.9% | 0.01% | -65.9% |
| Q3 2020 | $877,000 | +23.2% | 92,845 | +16.9% | 0.04% | +13.9% |
| Q2 2020 | $712,000 | – | 79,424 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |